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SECONDARY HYPERPARATHYROIDISM has been re-
ported by Stanbury and Lumb (21, 22) and Mas-
sry and his associates (14) to be present in most pa-
tients with chronic renal failure. After successful 
renal homotransplantation, it has been said by 
several investigators, including Alfrey and his col-
leagues (1) and Johnson and his co-workers (9, 10) 
that resolution of this hyperparathyroidism occurs 
almost universally. With conservative manage-
ment, severe hypercalcemia after renal transplan-
tation has been uncommon, and the dogma has 
become well established that parathyroidectomy 
is seldom required. 
This conservative attitude was based upon rel-
atively short term observations of renal recipients. 
In our center, there has been a growing realization 
that occult persistent hyperparathyroidism can be 
a major cause of morbidity, even more than five 
years after renal transplantation and in spite of 
multiple normal serum calcium concentrations. 
This article was undertaken, therefore, in order 
that the diagnosis of this complication might be 
described. 
The second reason for this study is to discuss the 
surgical therapy of post-transplantation hyper-
parathyroidism which, in everyone of our 18 pa-
tients, has been due to diffuse and multiglandular 
hyperplasia. Classic subtotal parathyroidectomy 
has been performed in half of our patients, and in 
the remainder, all the parathyroid tissue has been 
excised and a fraction of one gland returned as a 
free autograft. The advantages of both approaches 
for both long term and short term management 
will be mentioned. 
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METHODS 
Patient Material and Analyses 
Several hundred recipients of renal homografts 
are having follow-up studies done in our clinics 
from one month to ten years postoperatively. Of 
this total, 90 were screened during the last 18 
months for hyperparathyroidism, with total serum 
calcium and ionized serum calcium determina-
tions. Many of the patients also had measurement 
of 24 hour urine calcium excretion. None of the 
recipients who eventually were surgically treated 
for hyperparathyroidism were consistently hypo-
proteinemic, and even transient hypoproteinemia 
was diagnosed only two times. In our routine 
laboratories, the normal range for total serum cal-
cium in persons with normal serum proteins is 8.8 
to 10.8 milligrams per 100 milliliters by atomic ab-
sorption spectrophotometry and the concentration 
of ionized calcium, as determined by Orion® ion 
exchange electrode, is 4 to 4.9 milligrams per 100 
milliliters. 
In our transplant program, the population sam-
ple of 90 screened patients was not completely 
random, in that entry into the study was made 
more likely if a patient lived in or around Denver 
and, consequently, was receiving routine care at 
the University, if his or her clinical condition was 
not completely stable or satisfactory, if there were 
significant muscoskeletal complaints, and if the pa-
tients were in the relatively early phases of post-
transplantation convalescence. Conceding this bias, 
the number of patients who eventually underwent 
a parathyroidectomy was 18 of 90. Fifteen of the 18 
patients who underwent parathyroidectomy were 
treated with orally administered phosphate supple-
ments, as recommended by Alfrey and his associates 
(1) and Johnson and his colleagues (9, 10). In alliS 
recipients, 120 milliliters per day of the liquid ant-
acid, aluminum phosphate gel (Phosphaljel®) were 
given and, in a few instances, K-Acid-Phosphate® 
(potassium acid phosphate) was administered with 
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TABLE I.-CLINICAL DATA ON EIGHTEEN RENAL TRANSPLANT RECIPIENTS AFTER PARATHYROIDECTOMY 
Creatinine clearance Interval between __ Radiographic findings before parathyroidectomy __ 
after transplantation, transplantation and parathyroidectomy, ___ _ Bone disease ____ Extra-skeletal 
Age,yrs. ml./min. 
41 95 
22 70 
21 81 
10 55 
39 49 
43 90 
27 54 
30 90 
17 50 
13 Sl 
30 53 
48 89 
32 64 
11 46 
39 74 
24 87 
40 75 
~9 71 
* Osteitis fibrosa cystica histologically. 
t Aseptic necrosis femoral head. 
+, Presence of radiographic bone disease. 
-, Absence of radiographic bone disease. 
mos. 
2 
7 
14 
18 
20 
32 
47 
54 
63 
53 
6 
6 
18 
19 
39 
44 
2 
12 
the daily provision of 0.5 to 1.5 grams of elemental 
phosphorus. Many of these patients, as well as nu-
merous others who did not undergo parathyroidec-
tomy, also·had phosphorous concentrations deter-
mined in the urine and serum, using an autoanalyzer. 
Everyone of the screened patients had renal 
function measurements, including blood urea nitro-
gen, serum creatinine, and creatinine clearance. 
The skeletons of almost all the recipients were ex-
amined by radiographic bone surveys or by study 
of the bones by other roentgenographic procedures, 
such as intravenous pyelograms, gastrointestinal 
series, or routine chest examinations. 
The clinical data on the 18 patients who even-
tually underwent parathyroidectomy from two to 
63 months after transplantation are listed in Table 
1. Before transplantation, all of these recipients 
had renal failure, for at least several years, from 
glomerulonephritis, pyelonephritis, medullary cys-
tic disease, or polycystic disease, and in all but one 
patient hemodialysis was required. Their kidneys 
were obtained from 13 related and five cadaver 
donors, and all these grafts were still providing 
life-supporting function. Radiographic evidence of 
bone disease was present in 17 of the 18 patients, 
invariably including bone rarefaction. However, 
ten patients also had radiographic or pathologic 
evidence of osteitis fibrosa cystica or extraskeletal 
calcification in arteries or soft tissues, or both. 
In patients admitted to the hospital for para-
thyroidectomy, total and ionized serum calcium, 
phosphorus, creatinine, and blood urea nitrogen 
concentrations were obtained,for three consecutive 
Osteoporosis Osteitis fibrosa calcification 
+ Vascular 
+ Vascular 
+ Vas'cuiar 
+ 
+ + Soft tissue 
+ -* Vascular, skin 
+ 
+t Vascular, soft 
tissue 
+ 
+ + 
+ Vascular 
+t 
+ + Soft tissue 
+ 
+ 
+ -* Vascular 
+t 
days along with 24 hour determinations of urine 
calcium, phosphorus, and creatinine. Creatinine 
clearance, Ccr, and phosphate clearance, Cp were 
calculated in milliliters per minute, and the per 
cent tubular phosphate reabsorption, TPR, was 
derived from the formula 
TPR= (1-Cp/Ccr) 1 00. 
After parathyroidectomy, the same daily mea-
surements were obtained for at least ten days and 
intermittently thereafter for a maximum of 16 
months. 
Technique of Parathyroidectomy 
Subtotal parathyroidectomy. The thyroid and para-
thyroid glands were explored through the stan-
dard collar incision popularized by Halsted (7). A 
thorough search was made for the parathyroid 
glands. After identifying these, a gland with an 
easily identifiable arterial supply was sub totally 
amputated with a razor or scapel, leaving the small 
remnant on a vascular stalk. Bleeding from the raw 
surface was controlled with vascular suture or 
cautery. Only after visually establishing the viabil-
ity of the remnant were the other glands completely 
excised. If an accident occurred to the remains of 
the original gland, additional opportunities there-
by remained available until the last moment. 
In seven of the nine patients treated in this way, 
four glands were found, and, in the other two, 
there were three identifiable parathyroids. 
Autotransplantation. The same surgical incision 
was used (Fig. 1) with somewhat more complete 
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Sectioned parathyroid gland 
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I 
FIG. 1. Technique of parathyroid autotransplantation. A, The gland is re-
moved and sliced. Band C, Two of the slices are inserted into small pockets of 
sternocleidomastoid muscle and marked with No. 5-0 stainless steel wire. 
exposure of the left sternocleidomastoid muscle. 
After isolation of all of the parathyroid glands, 
these were completely removed. Two slices of one 
gland were fixed deeply within the sternocleido-
mastoid muscle, using No. 5 stainless steel wire to 
facilitate later identification of the implantation 
site, should that become necessary. Four glands 
were found in six of the nine patients treated with 
autotransplantation. Three glands only were found 
in two others, and five glands in the last one. 
Treatment Ajter Parathyroidectomy 
Postoperatively, the serum calcium value was 
allowed to decline to 7 to 8 milligrams per 100 
milliliters, or until hypocalcemic symptoms oc-
curred. 
Then, 450 milligrams of elemental calcium 
in the form of calcium gluconate were administered 
intravenously during a three hour interval. Con-
currently, calcium was orally administered every 
hour at an initial dose of 300 to 400 milligrams 
elemental calcium per hour given as calcium glu-
conate or calcium lactate. Later, during the con-
valescence, the orally administered calcium sup-
plement was slowly decreased over several weeks 
or months at a rate consistent with maintenance 
of the total serum calcium between 8 and 9 milli-
grams per 100 milliliters. 
---------_. __ .. _-_ .. ---
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FIG. 2. Course of total serum calcium' and ionized serum calcium in six patients 
prior to parathyroidectomy. The most consistent evidence of hyperparathyroidism 
was in the ionized calcium. Solid circles indicate that phosphate supplementation 
was being tried. Open circles denote the absence of phosphate supplementation. 
RESULTS 
Preoperative and Operative Findings 
Total and ionized calcium studies. Six of the patients 
had a diagnosis of hyperparathyroidism primarily 
because of a persistent elevation of the ionized 
serum calcium value (Fig. 2). In five of the six 
patients, the total serum calcium level initially had 
been high, but this fell promptly with the phos-
phate supplementation by means of the orally ad-
ministered antacid, Phosphaljel. Nevertheless, the 
ionized calcium value remained elevated. In the 
sixth patient, the ionized calcium level was high, 
although total calcium value never was elevated. 
A second group of six patients had total calcium 
levels that apparently were beneficially influenced 
by phosphate supplementation (Fig. 3). However, 
the control of the total calcium value was incom-
plete, with secondary rises, despite active treatment 
or with recurrence of hypercalcemia after dis-
continuance of phosphate therapy. All six of these 
patients had sporadic or continuously elevated 
ionized calcium, with or without phosphate ther-
apy. 
The final six patients had uncontrolled hyper-
calcemia either because they did not respond to 
phosphate therapy (Fig. 4a) or because they were 
not so treated (Fig. 4b). The ionized calcium 
values were elevated throughout in the five pa-
tients in whom they were measured. 
A direct relationship of the total serum calcium 
to the ionized calcium concentrations is shown in 
Figure 5 for all samples in 17 of thc 18 patients in 
which both determinations were obtained. The 
plotted data can bc divided into four subgroups 
within the total pool of 109 samples contributed 
by the 17 patients. The samplcs in the right upper 
quadrant containing 35 per cent of the samples had 
abnormally high total calcium, as well as ionized 
calcium, values, so that either of these chemical 
determinations would have revealed what proved 
to be a hyperparathyroid state. In contrast, the 
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FIG. 3. Course of total serum calcium and ionized serum calcium in six patients 
prior to parathyroidectomy. Solid circles indicate that phosphate supplementation 
was in effect, and the open circles denote the absence of such therapy. Note that 
the hypercalcemia was reduced by the phosphate treatment. 
left upper quadrant containing 44 per cent of the 
samples, had abnormally high ionized calcium 
values but with normal total calcium levels, as 
defined by an upper normal limit of 10.8 milli-
grams per cent. In this group, the standard total 
calcium determinations would have missed the 
diagnosis. In almost all the samples in the two 
lower quadrants, both the total and ionized serum 
levels were considered to be normal. 
It also was considered whether or not the cal-
cium changes were positively correlated with the 
steroid dosages used after transplantation. Enough 
calcium data were present in ten of the 18 patients 
of the reported series to permit examination of this 
question, and, in addition, two other well studied 
patients who did not undergo parathyroidectomy 
were included (Fig. 6). The total serum calcium 
levels tended to become elevated in these 12 pa-
tients as the prednisone dosages were reduced 
(Fig. 6). This observation could be interpreted as 
an indication that high dosages of glucocorticoids 
might have suppressed hypercalcemia and that 
this became apparent only as the dosage of pred-
nisone was reduced. 
The effect of phosphate supplementation. Fifteen of the 
18 patients eventually submitted to parathyroidec-
tomy were given phosphates orally after hyper-
parathyroidism was suspected. In four, the serum 
phosphorus was above 2.5 milligrams per cent be-
fore this treatment was started. The other 11 be-
gan with serum phosphate concentrations below 
2.5 milligrams per cent. With therapy, these con-
centrations could be raised to above 2.5 milligrams 
per cent, but, for the most part, the values re-
mained low normal (Fig. 7). 
Although the hypophosphatemia and total hy-
percalcemia often could be alleviated by this kind 
of phosphate therapy, the consequent effects upon 
the ionized calcium component were unpredict-
able. The relationship of the ionized serum calcium 
to the simultaneously determined serum phosphate 
on 102 occasions with or without phosphate ther-
~----------~----K----
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FIG. 4. Course of total serum calcium and ionized serum calcium in six patients 
prior to parathyroidectomy. a, Solid circles indicate phosphate supplementation, 
to which there was little or no response; open circles denote absence of this therapy. 
Ionized serum calcium determinations were not performed in the last patient (bot-
tom graph). b, Note that none of these patients received phosphate supplementa-
tion. 
apy in 17 of the patients who eventually under-
went parathyroidectomy is shown in Figure 8. An 
inverse relationship between ionized calcium and 
phosphorus is apparent, but in many instances, 
normal serum levels of phosphorus were associated 
with high ionized calcium, an indication that hy-
pophosphatemia was not a prerequisite to the 
occurrence of high ionized calcium. 
In many patients, tubular phosphate reabsorp-
tion was determined at the time of ionized serum 
calcium and the phosphate measurements. If the 
hypophosphatemia in these patients primarily was 
due to phosphate depletion rather than hyperpara-
thyroidism per se, the tubular phosphate reab-
sorption should have been at a maximum in those 
with hypophosphatemia. The converse actually 
was true, an indication that the diagnosis was hy-
perparathyroidism rather than phosphate deple-
tion (Fig. 9). Ionized serum calcium values bore 
an inverse relationship to the tubular phosphorous 
reabsorption (Fig. 10). However, tubular phos-
phorous reabsorption values in excess of 80 per cent 
were recorded with abnormally high ionized cal-
cium, emphasizing the limited diagnostic value of 
tubular phosphorous reabsorption. 
Diagnostic accuracy. All 18 patients were unequiv-
ocally shown, at the time of parathyroidectomy, to 
have hyperplasia by criteria of weight and micro-
scopic structure. Histopathologically, the diagnosis 
in all 18 patients was chief cell hyperplasia, and, 
in addition, an oxyphil clear cell adenoma was 
present in one specimen. Moreover, the gland tis-
sue removed weighed from 200 to 2,300 milligrams 
compared with an expected weight of 120 milli-
grams, as described by Pappenheimer and Willens 
(16). These results, which are summarized in Fig-
ure 11, indicate a perfect record of preoperative 
diagnostic accuracy. 
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Extrarenal complications. According to Stanbury 
and his co-workers (21, 22) and Massry (14) and 
his associates, the classical major complications of 
hyperparathyroidism are osteitis fibrosa cystic a, 
metastatic calcium deposition, and renal function 
deterioration. Because of the transplant setting, the 
renal function analyses will be considered sepa-
rately later on. Ten of the 18 patients had osteitis 
fibrosa cystica or metastatic calcium deposition, 
or both. Seven of the remaining eight recipients 
had only roentgenographic rarefaction as a bone 
complication and the eighth had no osseous ab-
normality. 
Postoperative 0 bservations 
Renal function. Fifteen of the 18 patients had re-
peated and detailed renal function determinations 
before and after parathyroidectomy. They were 
divided into three categories according to the renal 
functional status before operation and the response 
afterward. 
Four of the recipients had previously stable renal 
function. The parathyroidectomy had no percep-
tible subsequent effect (Fig. 12). Four more pa-
tients had progressive deterioration of renal func-
tion (Fig. 13). After parathyroidectomy, the losses 
ceased. Finally, seven patients with deteriorating 
renal function had a reversal of this process after 
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FIG. 5. Relation of the concentrations of total serum cal-
cium to ionized serum calcium in 109 samples from 17 pa-
tients. The vertical interrupted line is high normal total 
serum calcium value, 10.8 milligrams per cent. The hor-
izontal interrupted line is high normal ionized serum cal-
cium value, 4.9 milligrams per cent. The regression line 
crosses high normal serum ionized calcium where the total 
serum calcium concentration is 9.75 milligrams per cent. 
parathyroidectomy and without intensification of 
immunosuppressive therapy (Fig. 14). 
Subtotal parathyroidectomy. Two of the patients 
treated with subtotal parathyroidectomy died four 
UKM-~----~--~-----r----~--~----~----r----q----~--~ 
90 80 
PREDNISONE 
1nCJ124 hr 
FIG. 6. The relation of daily prednisone dosages to total serum calcium concentration in 12 pa-
tients in the absence of phosphate supplementation. The interrupted lines are from two patients 
who did not undergo parathyroidectomy but who received prednisone rapidly decreased and 
discontinued due to life-threatening infection. Note that hypercalcemia developed as the steroid 
dosages were diminished. 
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FIG. 11. The weights of parathyroid glands removed from 
17 patients. The range was from 200 to 2,300 milligrams, 
with a mean of 875. One weight was omitted, since the 
total weight was not recorded because one gland was im-
bedded in the thyroid. 
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FIG. 13. A stabilizing effect of parathyroidectomy, PTx, 
upon the deteriorating creatinine clearance of four patients. 
months and one month, respectively, after opera-
tion. The indication for parathyroid removal in the 
first patient was widespread cutaneous and sub-
cutaneous gangrene, apparently caused by occlu-
sion of small vessels by metastatic calcium. In 
spite of the parathyroidectomy, the complication 
led to death. The mortality a month after para-
thyroidectomy was caused by a perforated sigmoid 
diverticulum. In the latter patient, nephrocal-
cinosis was detected in the transplanted organ at 
autopsy. 
The complete early postoperative data depicted 
in Figure 15 was obtained in seven of the nine pa-
90 
80 
w UJ 70 
zu 
z~·R ~cr~ ~~b 
Uu 60 
50 
.0 
~o 
~_i 
oJ' ~ ~~l· 
19., .. 
, 
, 
, 
, 
i 
o 
~~ 
"~ElM1U 12 t 
PTx 
- MONTHS-
12 ,. 
FIG. 12. Lack of effect of parathyroidectomy, PTx, upon 
the creatinine clearance in milliliters per minute of four 
patients. 
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FIG. 14. An improvement of creatinine clearance in 
seven patients after parathyroidectomy, PTx. 
tients in the absence of any calcium supplementa-
tion. Observations in three of the patients are not 
shown after two to four days because of the need for 
calcium therapy. However, the serum concentra-
tions of both total and ionized calcium eventually 
became normal in all of these patients. 
Tubular reabsorption of phosphorus never be-
cmne complete in six of the seven fully studied pa-
tients and was 100 per cent for only four days in 
the seventh. With a longer follow-up period, the 
tubular reabsorption of phosphorus was variable 
but never 100 per cent. The subtotal parathy-
roidectomy was not responsible for any examples 
of hypoparathyroidism. In one patient, the typical 
biochemical findings of recurrent hyperparathy-
roidism developed almost a year after the para-
thyroid extirpation for an incidence of 11 per cent. 
-~---------------I-----------------
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FIG. 15. Total serum calcium, ionized serum calcium, 
and tubular reabsorption of phosphorus in seven patients 
who underwent subtotal parathyroidectomy, PTx. The 
final point on the total calcium curve of three of the seven 
patients was two to four days after operation and corre-
sponded with the onset of calcium supplementation. The 
dotted lines indicate two patients in whom only three para-
thyroid glands were found at exploration but who never 
required calcium supplementation. In those patients, a 
fourth gland was probably present. 
Parathyroid autotransplantation. All of these nine 
patients have survived to date for one to 12 
months after operation. The complete biochemical 
data given in Figure 16 was obtained in eight 
patients. In one patient, it was obvious that a gland 
was inadvertently left, in spite of the fact that four 
glands were removed. This patient did not have 
100 per cent tubular reabsorption of phosphorus, 
and calcium supplementation was not required. 
The other seven, completely studied patients 
promptly exhibited complete tubular reabsorp-
tion of phosphorus, usually within two or three 
days and, at the longest, by six days (Fig. 16). 
Moreover, there was a need in all seven patients for 
calcium supplementation. 
The course of the calcium therapy is presented 
in Figure 17 for the first six patients submitted to 
autotransplantation. Usually, 5 to 10 grams of ele-
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FIG. 16. Total serum calcium, ionized serum calcium, 
and tubular reabsorption of phosphorus in eight patients 
who underwent parathyroid autotransplantation. The final 
point on the total calcium curve in seven of the eight pa-
tients was two to five days after operation and corresponded 
with the onset of calcium supplementation. The inter-
rupted line indicates a ninth patient who had four para-
thyroid glands removed, never required calcium supple-
mentation, and never reached 100 per cent tubular reab-
sorption of phosphorus; a fifth gland was obviously present. 
mental calcium per day was begun, with an effort 
to wean the calcium dosage over the ensuing days 
and weeks. In all six of these patients, it became 
possible, within a few months, to stop the calcium 
altogether or to administer it in doses of less than 
2 grams per day. The return of tubular reabsorp-
tion of phosphorus was further proof of adequate 
parathyroid function. 
However, in one of the recently treated patients, 
there has been a persistent need for three or more 
grams per day of elemental calcium to maintain a 
total serum calcium level above 8. Although the 
tubular reabsorption of phosphorus in this last pa-
tient ranges from 60 to 80 per cent, persistent hy-
poparathyroidism has been diagnosed for an in-
cidence of one patient in nine. There has been no 
recurrence of hyperparathyroidism in the auto-
transplantation group. 
DISCUSSION 
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FIG. 17. Total serum calcium and tubular reabsorption of phosphorus or of calcium supplementa-
tions in six patients for the first several months after parathyroid autotransplantation. Five of the 
six required calcium supplementation for one to six months. The last patient, lower right-hand 
graph, never required calcium supplementation, never reached 100 per cent tubular reabsorption 
of phosphorus, and apparently had a retained gland. 
From autopsy studies and clinical observations, 
it has been well known for nearly a half century 
that parathyroid hyperfunction is a common find-
ing in patients with chronic renal disease, as sum-
marized by Stanbury and Lumb (21, 22), Massry 
and his colleagues (14) and Pappenheimer and 
Willens (16). The pathogenesis of secondary hy-
perparathyroidism is not well understood. How-
ever, two general mechanisms have been proposed. 
According to De Luca (6) and Avioli and his co-
workers (3), there is an acquired resistance to 
physiologic amounts of vitamin D, with an ab-
normal turnover rate of this vitamin leading to a 
decrease in ionized calcium and, hence, to second-
ary hyperparathyroidism. Bricker his associates (4) 
described a retention of phosphorus due to de-
creasing nephron population, resulting in increas-
K~------~----~------~ K"~--K------~ 
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ing serum phosphorous levels with a reciprocal 
decrease in ionized serum calcium and excessive 
stimulation of parathyroid hormone secretion. It 
has been estimated by Reiss and his associates (19) 
that this latter mechanism comes into play when 
renal function is reduced to below 80 per cent of 
its normal value. 
It is into this abnormal environment that many 
renal homografts are placed. Since the early days 
of renal transplantation, it has been thoroughly 
appreciated that this secondary hyperparathy-
roidism may persist into the postoperative period, 
as described by McIntosh (15), Schwartz and his 
colleagues (20) and Pletka and his associates (17). 
Popovtzer and his co~authors (18) have empha-
sized the difficulty of accuracy in the study of this 
problem because of the imperfections of the avail-
able parathormone assay methods. 
The published opinions by Alfrey and his asso-
ciates (1) and Johnson and his colleagues (9) have 
been strong that provision of adequate homeo-
stasis with a well functioning renal homograft 
should reverse the initiating chain of events, that 
the abnormal stimulus to the parathyroid glands 
should cease, and that the anatomic and functional 
aberrations of the parathyroid glands would un-
dergo involution. This impression has gained so 
much acceptance that it is widely believed that 
there is rarely any indication for parathyroidec-
tomy after renal transplantation. 
The information generated in our center in the 
last two years and herein reported has caused us to 
alter this conservative position. Although the exact 
incidence of sustained hyperparathyroidism cannot 
be accurately stated in our patient material, it now 
appears to be in excess of 20 per cen t. The insidious 
feature of this complication has been its occult and 
subtle nature which, in some instances, particularly 
in children, has permitted bone changes progressing 
to the creation of a pariah without ever having 
biochemically florid hyperparathyroidism. 
In our patients, the determination of total serum 
calcium and phosphorous concentrations has not 
provided an adequate screening for diagnosis. If an 
elevation in total serum calcium level were a pre-
requisite for the diagnosis, in eight of our 18 
patients, diagnosis never would have been made. In 
contrast, the ionized calcium level provided the 
decisive clue in every patient in which it was 
measured. Similar observations recently [laVe been 
published by Low and his associates (13) of the 
value of ionized calcium determinations to diag-
nose primary hyperparathyroidism. 
So far, the indications for parathyroidectomy 
after renal transplantation undoubtedly have been 
too restrictive. Now, caution must be exercised to 
avoid too much of a pendulum swing in the other 
direction. Nevertheless, the ultimate test of the 
accuracy of diagnosis in such instances should bc 
the unequivocal demonstration of hyperplastic 
changes in the glands. Histopathologically, this was 
so in all the parathyroid glands removed in our 
series, and in addition, these glands weighed from 
two to 50 timcs what would have been normal. 
It is tempting to speculate about some of the 
factors contributing to continuance of hyperpara-
thyroidism after relief of uremia by transplantation. 
Glucocorticoids may exert an indirect effect on 
parathyroid stimulation. This action would be 
mediated through suppression of serum calcium 
level, as described byJowscy and Balasubramaniam 
(11) and Laflamme and Jowsey (12). The appear-
ance of hypercalcemia in many of our patients only 
when the dosage of prednisone was reduced is con-
sistent with this action of glucocorticoids. Recently 
reported experimental results by Williams and his 
associ'ltes (23) support the notion that glucocorti-
coids both acutely and chronically may increase 
the secretion rate of parathyroid hormone. 
Alfrey and his associates (1) suggested that in 
patients after renal transplantation a state of 
phosphate depletion may develop which could con-
tribute to the development of hypercalcemia. They 
recommended a trial of repletion with phosphate-
containing antacids, such as Phosphaljel or with 
specific medication, such as potassium-acid-phos-
phate. This kind of phosphate supplementation 
probably is worth trying for a short period. But if 
required chronically, it may recreate the parathy-
roid stimulus by driving down the serum calcium 
concentration, or it could, theoretically, aggravate 
soft tissue calcification, as pointed out by Jowsey 
and Balasubramaniam (11) and Laflamme and 
Jowsey (12). Consequently, parathyroidectomy 
should be strongly considered after a three months' 
trial of conservative treatment if there is a recur-
rence of the hyperparathyroid state after phos-
phates are stopped. The impetus to proceed should 
be increased if there are serious bone complications 
in the background or if there is a deterioration of 
renal homograft function unexplained on im-
munologic grounds. Almost two-thirds of the pa-
tients in the present series had deteriorating renal 
function prior to parathyroidectomy. After opera-
tion, this decline usually was either halted or 
reversed. 
The classical approach to diffuse parathyroid 
byperplasia has been complete removal of all but 
one of the parathyroid glands and subtotal resection 
of this last gland, as described by Cope (5). The 
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results with this procedure were satisfactory in the 
present series, except for a patient in whom there 
was a recurrence within a year. The advantage of 
this approach was that no permanent hypopara-
thyroid states were created and in the fact that the 
majority of the patients never required calcium 
supplementations. 
The alternative method of autotransplantation, 
as originally described by Halsted and Evans (8) 
and recently revived by Alveryd (2), also was given 
a trial. This technique has a major advantage in 
that it permits a precise determination by simple 
metabolic studies carried out within the first post-
operative week as to whether or not all the glands 
had been identified. If all glands were found and re-
moved, the tubular reabsorption of phosphorus 
should become 100 per cent within a few days. 
Failure to demonstrate this signifies that the pro-
cedure was incomplete. With this test, it was evi-
dent that one of the nine patients in our series who 
underwent autotransplantation had an undetected 
gland. 
In spite of this impressive advantage of auto-
transplantation, the procedure cannot as yet be 
recommended for general use because of its poten-
tial disadvantages both early and late. Immediately 
postoperatively, all patients require calcium sup-
plementation for several weeks while the autograft 
becomes established. Furthermore, failure of the 
implant to be vascularized could lead to permanent 
hypoparathyroidism, as may be occurring in one 
of our most recently treated patients. Finally, it is 
conceivable that the cicatricial capsule around an 
established homograft might, in the long run, 
squeeze off the implant blood supply many months 
or even years later. Consequently, it is our plan 
to carefully observe the nine patients thus far 
treated by autotransplantation for one or two years 
before making a final judgment. Until then, sub-
total parathyroidectomy will remain our first 
choice. 
SUMMARY 
In the last 18 months, 90 patients who had been 
treated successfully from a few weeks to almost ten 
years previously with renal homotransplantation 
were screened for hyperparathyroidism with the 
usual diagnostic techniques and determinations of 
ionized serum calcium concentrations. Eighteen of 
the 90 recipients eventually were shown by histo-
pathologic criteria to have diffuse parathyroid 
hyperplasia. The removed parathyroid tissue 
weighed 200 to 2,300 milligrams. 
Prior to parathyroid excision, the hyperparathy-
roid state was correctly identified by the elevated 
ionized calcium values, whereas the diagnosis often 
would have been missed if reliance had been placed 
upon total serum calcium, serum phosphorus, 
tubular reabsorption of urinary phosphorus, or 
other determinations. All but one of the 18 patients 
submitted to parathyroidectomy had bone disease 
or metastatic soft tissue calcification, and more 
than half had pronounced deterioration of renal 
function, which was halted or reversed by relief 
of the hyperparathyroidism. Before resorting to 
parathyroidectomy, 15 of the 18 patients were 
given a trial of orally administered phosphate sup-
plementation. This treatment reduced the total 
serum calcium concentration but had much less 
effect on the ionized calcium and, if used chronical-
ly, may have perpetuated the stimulus for para-
thormone secretion. 
Nine patients underwent total parathyroidec-
tomy, with parathyroid autoimplantation of seg-
ments of one of the hyperplastic glands. The other 
nine patients had classical subtotal parathyroidec-
tomy. Just after autotransplantation, profound 
hypocalcemia always occurred with 100 per cent 
tubular phosphate reabsorption, calcium supple-
mentation being required, which was decreased to 
a minimum or discontinued after two to six months. 
One of the nine patients had significant hypopara-
thyroidism. After subtotal parathyroidectomy, there 
were no examples of hypoparathyroidism, but there 
has been one example of recurrent hyperparathy-
roidism. 
These data indicate an alarmingly high inci-
dence of persistent and often occult secondary hy-
perparathyroidism in renal transplant recipients, 
which is not effectively treated with phosphate 
supplementation; the importance of ionized serum 
calcium determinations in diagnosing this compli-
cation; a harmful effect of hyperparathyroidism on 
transplanted kidneys; and the potential value of 
parathyroid autotransplantation in these patients 
to determine the presence of a fifth gland or other 
retained hyperplastic tissue which may cause recur-
rence. Subtotal parathyroidectomy will remain the 
operation of choice for diffuse parathyroid hyper-
plasia until more information about the long term 
outcome after total parathyroidectomy and auto-
transplantation becomes available. 
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